Bill Enright will step down as president and CEO of Gaithersburg-based Altimmune Inc. (NASDAQ: ALT), after leading the company through more than a decade of growth involving acquisitions and an initial public offering. “I think this is the right time for me,” Enright said in an interview Tuesday. “I’ve been with the company a little over 10 years and transitioned this from a little lab in Birmingham, Alabama, through two acquisitions, and going public, and getting some solid clinical data…
from https://www.bizjournals.com/baltimore/news/2018/10/24/gaithersburg-biotech-ceo-to-step-down.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/179383329012
No comments:
Post a Comment